冷等离子体处理对生鲜鸡胸肉杀菌效果及品质影响

目的 研究沿面介质阻挡放电(Surface Dielectric Barrier Discharge,SDBD)等离子体对生鲜鸡胸肉的杀菌作用及品质影响。方法 采用放电功率为260 W的SDBD等离子体分别处理生鲜鸡胸肉2 min和4 min,并于4 ℃贮藏12 d。每隔3 d取样,测定菌落总数、色泽、pH、汁液流失率、硫代巴比妥酸反应物(Thiobarbituric Acid Reactive Substances,TBARS)含量、挥发性盐基氮(Total Volatile Basic Nitrogen,TVB-N)含量及质构特性。结果 经SDBD等离子体处理2 min或4 min,并于4 ℃贮藏12 d后,生鲜鸡胸肉的菌落总数分别为7.16 lg(CFU/g)和6.70 lg(CFU/g),均低于对照组样品的菌落总数(7.55 lg(CFU/g))。此外,SDBD等离子体处理能够显著(P<0.05)改善冷藏期间鸡胸肉的品质参数,如pH、色泽(L^*、a^*和b^*)、汁液流失率、TVB–N含量和质构特性(硬度、弹性、咀嚼性等),但对脂质氧化具有促进作用。结论 SDBD等离子体对生鲜鸡胸肉具有良好的杀菌效果,并有效保持了其品质,在鸡胸肉保鲜上具有巨大的应用前景。     

光敏剂在光动力治疗中的应用研究进展

光动力疗法（PDT）以其超高时空分辨率、非侵入性及低毒副作用的优点,被认为是治疗癌症和各种非恶性疾病的有效疗法之一。本文主要综述了几类光敏剂发展历史、主要结构、特点及研究进展,分析了高性能光敏剂的开发动态,包括化学修饰;与具有特定细胞受体的其他配体缀合成复合光敏剂;采取纳米技术,如纳米颗粒输送,基于富勒烯的光敏剂等。基于此,指出具有临床应用前景的高性能光敏剂的基本特征、设计原则及发展趋势。     

Synthesis and in vitro Anticancer Activity of Zinc(II) Phthalocyanines Conjugated with Coumarin Derivatives for Dual Photodynamic and Chemotherapy

The combination of photodynamic therapy and chemotherapy is a promising strategy to overcome growing problems in contemporary medicine, such as low therapeutic efficacy and drug resistance. Four zinc(II) phthalocyanine–coumarin conjugates were synthesized and characterized. In these complexes, zinc(II) phthalocyanine was used as the photosensitizing unit, and a coumarin derivative was selected as the cytostatic moiety; the two components were linked via a tri(ethylene glycol) chain. These conjugates exhibit high photocytotoxicity against HepG2 human hepatocarcinoma cells, with low IC₅₀ values in the range of 0.014–0.044 μM . The high photodynamic activities of these conjugates are in accordance with their low aggregation tendency and high cellular uptake. One of these conjugates exhibits high photocytotoxicity and significantly higher chemocytotoxicity. The results clearly show that the two antitumor components in these conjugates work in a cooperative fashion. As shown by confocal microscopy, the conjugates can localize in the mitochondria and lysosomes, and one of the conjugates can also localize in the cell nuclei.     

Usefulness of Photodynamic Therapy as a Possible Therapeutic Alternative in the Treatment of Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common cancer in individuals with fair skin type (I–II) and steadily increasing in incidence (70% of skin malignancy). It is locally invasive but metastasis is usually very rare, with an estimated incidence of 0.0028%–0.55%. Conventional therapy is surgery, especially for the H region of the face and infiltrative lesions; in case of inoperable tumors, radiotherapy is a valid option. Recently, topical photodynamic therapy (PDT) has become an effective treatment in the management of superficial and small nodular BCC. PDT is a minimally invasive procedure that involves the administration of a photo-sensibilizing agent followed by irradiation at a pre-defined wavelength; this determines the creation of reactive oxygen species that specifically destroy target cells. The only major side effect is pain, reported by some patients during the irradiation. The high cure rate and excellent cosmetic outcome requires considering this possibility for the management of patients with both sporadic and hereditary BCC. In this article, an extensive review of the recent literature was made, in order to clarify the role of PDT as a possible alternative therapeutic option in the treatment of BCC.     

Insulin-Like Growth Factor-2 Is Induced Following 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in SW620 Human Colon Cancer Cell Line

The IGF system is a family of polypeptide growth factors, which plays a significant role in the development and growth of many cells. Dysregulation of insulin-like growth factors and their pathway components has been connected with essential tumor properties, such as tumor cell proliferation, antiapoptotic properties, invasive behavior and chemotherapy resistance. However, the effects of photodynamic therapy (PDT), one of the cancer treatment methods for the regulation of the IGF signaling pathway, are still unclear. The aim of this study was to investigate the expression of IGF-2 after 5-aminolevulinic acid (5-ALA)-mediated-PDT in SW620 human colorectal cancer cells with evaluation of cell proliferation and apoptosis and to determine the effects of PDT on the IGF-2 receptor (IGF-2R), IGF-2 binding protein-1 (IGF-2BP-1) and the proapoptotic protein, BAX. Cells were treated with 5-aminolevulinic acid and its methyl ester. Changes of the expression and concentration of IGF-2 before and after treatment were assayed by immunocytochemistry, Western blot and ELISA. We found that IGF-2 was significantly overexpressed in the SW620 cell line, while its receptor and binding protein-1 were not significantly changed. Within this study, we would like to suggest that IGF-2 contributes to the effects of PDT and that its expression will influence post-PDT efficacy.     

New Peptide-Conjugated Chlorin-Type Photosensitizer Targeting Neuropilin-1 for Anti-Vascular Targeted Photodynamic Therapy

Photodynamic therapy (PDT) is a cancer treatment modality that requires three components, namely light, dioxygen and a photosensitizing agent. After light excitation, the photosensitizer (PS) in its excited state transfers its energy to oxygen, which leads to photooxidation reactions. In order to improve the selectivity of the treatment, research has focused on the design of PS covalently attached to a tumor-targeting moiety. In this paper, we describe the synthesis and the physico-chemical and photophysical properties of six new peptide-conjugated photosensitizers designed for targeting the neuropilin-1 (NRP-1) receptor. We chose a TPC (5-(4-carboxyphenyl)-10,15, 20-triphenyl chlorine as photosensitizer, coupled via three different spacers (aminohexanoic acid, 1-amino-3,6-dioxaoctanoic acid, and 1-amino-9-aza-3,6,12,15-tetraoxa-10-on-heptadecanoic acid) to two different peptides (DKPPR and TKPRR). The affinity towards the NRP-1 receptor of the conjugated chlorins was evaluated along with in vitro and in vivo stability levels. The tissue concentration of the TPC-conjugates in animal model shows good distribution, especially for the DKPPR conjugates. The novel peptide–PS conjugates proposed in this study were proven to have potential to be further developed as future NRP-1 targeting photodynamic therapy agent.     

QUANTITATION OF PROTEIN DAMAGE IN METAL ION-CATALYZED OXIDATION SYSTEMS

The loss of enzymatic activity of lactate dehydrogenase was studied in several ascorbate, iron and hydrogen peroxide metal catalyzed oxidation solutions in which the initial concentration of each reactant was varied independently. Nonmonotonic concentration dependencies of enzymatic inactivation were observed for all three reactants. with minimum activity levels occurring in the 0·1 to 8 mM range. A first effort has been made to predict these concentration dependencies with a mathematical simulation model. The model consisted of the most commonly reported reactions and assumed that protein damage occurred through reaction with the hydroxyl radical. The simulation predicted nonmonotonic concentration dependencies of enzyme inactivation on each of the reactants. The predicted concentrations of the minima differed from the experimentally observed points by a factor of 2 to 4. Mathematically the minima occurred because each reactant was reported to react with hydroxyl radicals and form less reactive compounds. The plausibility that competition caused or contributed to the extrema was further explored with experimental competition studies between peroxide and the radical scavenger dimethylsulfoxide. A point of maximum hydroxyl radical formation was observed with increasing peroxide concentration. This maxima corresponded to the point of maximum lactate dehydrogenase damage observed with increasing peroxide concentration.     

Stable Synthetic Bacteriochlorins for Photodynamic Therapy: Role of Dicyano Peripheral Groups,Central Metal Substitution (2H,Zn, Pd), and Cremophor EL Delivery

A series of four stable synthetic bacteriochlorins was tested in vitro in HeLa cells for their potential in photodynamic therapy (PDT). The parent bacteriochlorin (BC), dicyano derivative (NC)₂BC and corresponding zinc chelate (NC)₂BC–Zn and palladium chelate (NC)₂BC–Pd were studied. Direct dilution of a solution of bacteriochlorin in an organic solvent (N,N‐dimethylacetamide) into serum‐containing medium was compared with the dilution of bacteriochlorin in Cremophor EL (CrEL; polyoxyethylene glycerol triricinoleate) micelles into the same medium. CrEL generally reduced aggregation (as indicated by absorption and fluorescence) and increased activity up to tenfold (depending on bacteriochlorin), although it decreased cellular uptake. The order of PDT activity against HeLa human cancer cells after 24 h incubation and illumination with 10 J cm^?2 of near‐infrared (NIR) light is (NC)₂BC–Pd (LD₅₀=25 nM ) > (NC)₂BC > (NC)₂BC–Zn ≈ BC. Subcellular localization was determined to be in the endoplasmic reticulum, mitochondria and lysosomes, depending on the bacteriochlorin. (NC)₂BC–Pd showed PDT‐mediated damage to mitochondria and lysosomes, and the greatest production of hydroxyl radicals as determined using a hydroxyphenylfluorescein probe. The incorporation of cyano substituents provides an excellent motif for the enhancement of the photoactivity and photostability of bacteriochlorins as PDT photosensitizers.     

低pH胃蛋白酶-甲苯消化法灭活破伤风免疫血浆中脂包膜病毒效果验证

目的验证低pH条件下胃蛋白酶-甲苯消化法对不同核酸类型的脂包膜病毒的灭活效果。方法以水疱性口炎病毒(Vesicular stomatitis virus,VSV)作为RNA指示病毒,以伪狂犬病病毒(Pseudorabies virus,PRV)作为DNA指示病毒,将破伤风免疫血浆样品经低pH(3.2±0.2)、0.2%甲苯、6～12活力单位胃蛋白酶处理后各取27 ml,分别加入3 ml指示病毒(9∶1),在(30.0±1)℃水浴中分别振摇10、30、60、90 min灭活病毒。以Vero细胞、PK-15细胞为基质,采用96孔细胞病变法检测残余病毒滴度,验证病毒灭活效果。结果破伤风免疫血浆样品经低pH胃蛋白酶及甲苯消化处理90 min后,VSV和PRV两种指示病毒的灭活效果分别为3.12～3.88和5.25～5.38 logTCID50/0.1 ml。结论采用低pH胃蛋白酶-甲苯消化法对破伤风免疫血浆中PRV灭活效果较好,而对VSV灭活效果有待提高。     

Animal Models for Photodiagnosis and Photodynamic Therapy

A prerequisite for starting a clinical trial is evidence of a positive impact of the technique or drug in animals. The choice of the animal model is thus very important and should mimic as closely as possible the human situation. A variety of animal models have been validated for pharmaceutical trials. The situation in phototheranostics however is not fully clear. This is due to the very complex interplay of various elements such as vascularization, oxygenation, drug availability and biodistribution, light absorption, and scattering. The present paper will give general information on aspects of animal models that have to be considered in phototheranostics, as well as highlight some typical animal models that are useful for the investigation of light-tissue interactions.